Correlation Between Eliem Therapeutics and Navidea Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Navidea Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Navidea Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Navidea Biopharmaceuticals, you can compare the effects of market volatilities on Eliem Therapeutics and Navidea Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Navidea Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Navidea Biopharmaceutica.
Diversification Opportunities for Eliem Therapeutics and Navidea Biopharmaceutica
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eliem and Navidea is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Navidea Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Navidea Biopharmaceutica and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Navidea Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Navidea Biopharmaceutica has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Navidea Biopharmaceutica go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Navidea Biopharmaceutica
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.03 times less return on investment than Navidea Biopharmaceutica. But when comparing it to its historical volatility, Eliem Therapeutics is 1.09 times less risky than Navidea Biopharmaceutica. It trades about 0.03 of its potential returns per unit of risk. Navidea Biopharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 10.00 in Navidea Biopharmaceuticals on August 28, 2024 and sell it today you would lose (0.04) from holding Navidea Biopharmaceuticals or give up 0.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.26% |
| Values | Daily Returns |
Eliem Therapeutics vs. Navidea Biopharmaceuticals
Performance |
| Timeline |
| Eliem Therapeutics |
| Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Eliem Therapeutics and Navidea Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Navidea Biopharmaceutica
The main advantage of trading using opposite Eliem Therapeutics and Navidea Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Navidea Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Navidea Biopharmaceutica will offset losses from the drop in Navidea Biopharmaceutica's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |